• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Keywords » aripiprazole

Items Tagged with 'aripiprazole'

ARTICLES

Research Update

Low-Dose Aripiprazole for Youth With Anorexia

April 1, 2026
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joshua Feder, MD
Dr. Feder has no financial relationships with companies related to this material.

When family-based therapy stalls in adolescents with anorexia, what comes next? A retrospective matched-cohort study suggests that low-dose aripiprazole may loosen cognitive rigidity enough to get treatment moving again — with doses averaging under 3 mg/day and a surprisingly favorable side-effect profile.


Read More
Research Update

Prenatal Antipsychotic Exposure: Reassuring Long-Term Data

April 1, 2026
Victoria Hendrick, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Victoria Hendrick, MD. Dr. Hendrick has no financial relationships with companies related to this material.

Do antipsychotics during pregnancy increase long-term neurodevelopmental risk? Large US and Nordic registry studies, along with prospective data, provide reassuring findings. After adjusting for maternal illness, prenatal exposure was not meaningfully associated with intellectual, language, or learning disorders—important context for shared decision-making.


Read More
Research Update

Lithium as Effective as IV Ketamine Augmentation in Treatment-Resistant Depression

October 1, 2025
Alex Evans, PharmD, MBA.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

The analysis ranks the efficacy of ketamine, esketamine, lithium, and aripiprazole in TRD.


Read More
Research Update

Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia

January 1, 2025
Sarah Azarchi, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.

Five strategies to reduce prolactin on antipsychotics tested in this meta-analysis


Read More
Abilify_Video_thumb.png

Optimal Abilify Dose for Depression (MDD Augmentation with Aripiprazole)

August 13, 2024
Richard Moldawsky, MD and Greg Malzberg, MD

This video breaks down the findings from a meta-analysis of randomized controlled trials, examining how aripiprazole dosage impacts patient outcomes in clinical depression treatment.



Read More
Research Update

Long-Acting Injectable Antipsychotics and Risk of Hospitalization

October 3, 2023
Brian Holoyda, MD, MPH, MBA
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Brian Holoyda, MD. Dr. Holoyda has no financial relationships with companies related to this material.

By initiating LAIs early in the course of a patient’s illness, we can significantly delay the time to first hospitalization in young adults. 


Read More
Research Update

Antipsychotics in Pregnancy and Risk of Neurodevelopmental Disorders

October 3, 2023
Sébastien Hardy, PharmD, BCPS.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, PharmD, BCPS. Dr. Hardy has no financial relationships with companies related to this material.

This large study gives us reassuring data about neurodevelopmental outcomes in children exposed to several second-generation antipsychotic medications during pregnancy.


Read More
Clinical Update

Treating Irritability in Autism: Functional and Medication Approaches

April 1, 2023
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joshua D. Feder, MD. Editor-in-Chief, The Carlat Child Psychiatry Report.

Dr. Feder has no financial relationships with companies related to this material.

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediate prescribes antipsychotics. There are usually multiple steps to try before using the FDA approved antipsychotic medications.


Read More
RESEARCH UPDATE

Aripiprazole-Related Psychotic Exacerbations

January 1, 2023
Brian Miller, MD, PhD, MPH.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Brian Miller, MD, PhD, MPH. Dr. Miller, author of this educational activity, receives research support from Augusta University, the National Institute of Mental Health, the Brain and Behavior Research Foundation, and the Stanley Medical Research Institute. Relevant financial relationships listed for the author have been mitigated.

This study identifies a common clinical scenario where aripiprazole may trigger psychotic symptoms.


Read More

Aripiprazole in Depression: The Right Dose

September 25, 2022
Richard Moldawsky, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Richard Moldawsky, MD. Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dosing recommendations for aripiprazole vary widely in depression, from 2 mg to 15 mg, but this meta-analysis finds a sweet spot in the lower range.


Read More
More Articles Tagged with 'aripiprazole'
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2772531237.jpg
    General Psychiatry

    Gender Affirming Care in Exile: The Lawsuits

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.